Cite
GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
MLA
Joonho Suh, et al. “GDF11 Promotes Osteogenesis as Opposed to MSTN, and Follistatin, a MSTN/GDF11 Inhibitor, Increases Muscle Mass but Weakens Bone.” Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 9, Mar. 2020, pp. 4910–20. EBSCOhost, https://doi.org/10.1073/pnas.1916034117.
APA
Joonho Suh, Na-Kyung Kim, Seung-Hoon Lee, Je-Hyun Eom, Youngkyun Lee, Joo-Cheol Park, Kyung Mi Woo, Jeong-Hwa Baek, Jung-Eun Kim, Hyun-Mo Ryoo, Se-Jin Lee, & Yun-Sil Lee. (2020). GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone. Proceedings of the National Academy of Sciences of the United States of America, 117(9), 4910–4920. https://doi.org/10.1073/pnas.1916034117
Chicago
Joonho Suh, Na-Kyung Kim, Seung-Hoon Lee, Je-Hyun Eom, Youngkyun Lee, Joo-Cheol Park, Kyung Mi Woo, et al. 2020. “GDF11 Promotes Osteogenesis as Opposed to MSTN, and Follistatin, a MSTN/GDF11 Inhibitor, Increases Muscle Mass but Weakens Bone.” Proceedings of the National Academy of Sciences of the United States of America 117 (9): 4910–20. doi:10.1073/pnas.1916034117.